Literature DB >> 25027322

The ras responsive transcription factor RREB1 is a novel candidate gene for type 2 diabetes associated end-stage kidney disease.

Jason A Bonomo1, Meijian Guan2, Maggie C Y Ng2, Nicholette D Palmer3, Pamela J Hicks2, Jacob M Keaton2, Janice P Lea4, Carl D Langefeld5, Barry I Freedman6, Donald W Bowden7.   

Abstract

Familial clustering and presumed genetic risk for type 2 diabetic (T2D) and non-diabetic end-stage kidney disease (ESKD) appear strong in African Americans. Examination of exome sequencing data in African American T2D-ESKD cases and non-diabetic non-nephropathy controls identified two low-frequency variants in the RREB1 gene, a repressor of the angiotensinogen (AGT) gene previously associated with kidney function, as being associated with T2D-ESKD: rs9379084 (P = 0.00087, OR = 0.26; D1171N) and rs41302867 (P = 0.00078, OR = 0.21; splice site variant). Rs41302867 replicated association in an independent sample of African Americans with T2D-ESKD [rs41302867 P = 0.033 (OR = 0.50)], and a trend towards rs9379084 association was observed (P = 0.070). In European Americans with T2D-ESKD compared with European American population based controls, both RREB1 variants replicated association [rs9379084 P = 1.67 × 10(-4) (OR = 0.54) and rs41302867 P = 0.013 (OR = 0.69)]. Rs9379084 was not associated with non-T2D-ESKD or T2D in African Americans (P = 0.55 and P = 0.37, respectively), but was associated with T2D in European Americans (P = 0.014, OR = 0.65). In African Americans, rs41302867 was associated with non-T2D-ESKD [P = 0.036 (OR = 0.54)] and hypertension attributed ESKD [H-ESKD, P = 0.029 (OR = 0.50)]. A meta-analysis combining African American and European American T2D-ESKD data revealed P = 3.52 × 10(-7) and 3.70 × 10(-5) for rs9379084 and rs41302867 association, respectfully. A locus-wide analysis evaluating putatively functional SNPs revealed several nominal associations with T2D-ESKD, non-T2D-ESKD and T2D in African and European Americans. RREB1 is a large, complex gene which codes a multidomain zinc finger binding protein and transcription factor. We posit that variants in RREB1 modulate seemingly disparate phenotypes (i.e. T2D, T2D-ESKD and non-T2D-ESKD) through altered activity resulting from splice site and missense variants.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25027322      PMCID: PMC4240197          DOI: 10.1093/hmg/ddu362

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  27 in total

1.  Finb, a multiple zinc finger protein, represses transcription of the human angiotensinogen gene.

Authors:  Shoichi Date; Yutaka Nibu; Kazuyuki Yanai; Jun Hirata; Ken-Ichi Yagami; Akiyoshi Fukamizu
Journal:  Int J Mol Med       Date:  2004-05       Impact factor: 4.101

2.  Novel transcriptional potentiation of BETA2/NeuroD on the secretin gene promoter by the DNA-binding protein Finb/RREB-1.

Authors:  Subir K Ray; Junko Nishitani; Mary W Petry; Michael Y Fessing; Andrew B Leiter
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

3.  A novel zinc finger protein, Finb, is a transcriptional activator and localized in nuclear bodies.

Authors:  A Fujimoto-Nishiyama; S Ishii; S Matsuda; J Inoue; T Yamamoto
Journal:  Gene       Date:  1997-08-22       Impact factor: 3.688

4.  Stimulation of pancreatic growth by secretin, caerulein, and pentagastrin.

Authors:  A B Dembinski; L R Johnson
Journal:  Endocrinology       Date:  1980-01       Impact factor: 4.736

5.  p16 INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB.

Authors:  Shuling Zhang; Xiaolan Qian; Chanelle Redman; Valeri Bliskovski; Edward S Ramsay; Douglas R Lowy; Beverly A Mock
Journal:  Oncogene       Date:  2003-04-17       Impact factor: 9.867

6.  Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.

Authors:  Giuseppe Pandini; Rossana Mineo; Francesco Frasca; Charles T Roberts; Marco Marcelli; Riccardo Vigneri; Antonino Belfiore
Journal:  Cancer Res       Date:  2005-03-01       Impact factor: 12.701

7.  The zinc finger protein ras-responsive element binding protein-1 is a coregulator of the androgen receptor: implications for the role of the Ras pathway in enhancing androgenic signaling in prostate cancer.

Authors:  Nishit K Mukhopadhyay; Bekir Cinar; Lipi Mukhopadhyay; Mohini Lutchman; Angeline S Ferdinand; Jayoung Kim; Leland W K Chung; Rosalyn M Adam; Subir K Ray; Andrew B Leiter; Jerome P Richie; Brian C-S Liu; Michael R Freeman
Journal:  Mol Endocrinol       Date:  2007-06-05

8.  Familial risk, age at onset, and cause of end-stage renal disease in white Americans.

Authors:  B J Spray; N G Atassi; A B Tuttle; B I Freedman
Journal:  J Am Soc Nephrol       Date:  1995-04       Impact factor: 10.121

9.  A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.

Authors:  Laura J Scott; Karen L Mohlke; Lori L Bonnycastle; Cristen J Willer; Yun Li; William L Duren; Michael R Erdos; Heather M Stringham; Peter S Chines; Anne U Jackson; Ludmila Prokunina-Olsson; Chia-Jen Ding; Amy J Swift; Narisu Narisu; Tianle Hu; Randall Pruim; Rui Xiao; Xiao-Yi Li; Karen N Conneely; Nancy L Riebow; Andrew G Sprau; Maurine Tong; Peggy P White; Kurt N Hetrick; Michael W Barnhart; Craig W Bark; Janet L Goldstein; Lee Watkins; Fang Xiang; Jouko Saramies; Thomas A Buchanan; Richard M Watanabe; Timo T Valle; Leena Kinnunen; Gonçalo R Abecasis; Elizabeth W Pugh; Kimberly F Doheny; Richard N Bergman; Jaakko Tuomilehto; Francis S Collins; Michael Boehnke
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

10.  Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility.

Authors:  Anubha Mahajan; Min Jin Go; Weihua Zhang; Jennifer E Below; Kyle J Gaulton; Teresa Ferreira; Momoko Horikoshi; Andrew D Johnson; Maggie C Y Ng; Inga Prokopenko; Danish Saleheen; Xu Wang; Eleftheria Zeggini; Goncalo R Abecasis; Linda S Adair; Peter Almgren; Mustafa Atalay; Tin Aung; Damiano Baldassarre; Beverley Balkau; Yuqian Bao; Anthony H Barnett; Ines Barroso; Abdul Basit; Latonya F Been; John Beilby; Graeme I Bell; Rafn Benediktsson; Richard N Bergman; Bernhard O Boehm; Eric Boerwinkle; Lori L Bonnycastle; Noël Burtt; Qiuyin Cai; Harry Campbell; Jason Carey; Stephane Cauchi; Mark Caulfield; Juliana C N Chan; Li-Ching Chang; Tien-Jyun Chang; Yi-Cheng Chang; Guillaume Charpentier; Chien-Hsiun Chen; Han Chen; Yuan-Tsong Chen; Kee-Seng Chia; Manickam Chidambaram; Peter S Chines; Nam H Cho; Young Min Cho; Lee-Ming Chuang; Francis S Collins; Marylin C Cornelis; David J Couper; Andrew T Crenshaw; Rob M van Dam; John Danesh; Debashish Das; Ulf de Faire; George Dedoussis; Panos Deloukas; Antigone S Dimas; Christian Dina; Alex S Doney; Peter J Donnelly; Mozhgan Dorkhan; Cornelia van Duijn; Josée Dupuis; Sarah Edkins; Paul Elliott; Valur Emilsson; Raimund Erbel; Johan G Eriksson; Jorge Escobedo; Tonu Esko; Elodie Eury; Jose C Florez; Pierre Fontanillas; Nita G Forouhi; Tom Forsen; Caroline Fox; Ross M Fraser; Timothy M Frayling; Philippe Froguel; Philippe Frossard; Yutang Gao; Karl Gertow; Christian Gieger; Bruna Gigante; Harald Grallert; George B Grant; Leif C Grrop; Chrisropher J Groves; Elin Grundberg; Candace Guiducci; Anders Hamsten; Bok-Ghee Han; Kazuo Hara; Neelam Hassanali; Andrew T Hattersley; Caroline Hayward; Asa K Hedman; Christian Herder; Albert Hofman; Oddgeir L Holmen; Kees Hovingh; Astradur B Hreidarsson; Cheng Hu; Frank B Hu; Jennie Hui; Steve E Humphries; Sarah E Hunt; David J Hunter; Kristian Hveem; Zafar I Hydrie; Hiroshi Ikegami; Thomas Illig; Erik Ingelsson; Muhammed Islam; Bo Isomaa; Anne U Jackson; Tazeen Jafar; Alan James; Weiping Jia; Karl-Heinz Jöckel; Anna Jonsson; Jeremy B M Jowett; Takashi Kadowaki; Hyun Min Kang; Stavroula Kanoni; Wen Hong L Kao; Sekar Kathiresan; Norihiro Kato; Prasad Katulanda; Kirkka M Keinanen-Kiukaanniemi; Ann M Kelly; Hassan Khan; Kay-Tee Khaw; Chiea-Chuen Khor; Hyung-Lae Kim; Sangsoo Kim; Young Jin Kim; Leena Kinnunen; Norman Klopp; Augustine Kong; Eeva Korpi-Hyövälti; Sudhir Kowlessur; Peter Kraft; Jasmina Kravic; Malene M Kristensen; S Krithika; Ashish Kumar; Jesus Kumate; Johanna Kuusisto; Soo Heon Kwak; Markku Laakso; Vasiliki Lagou; Timo A Lakka; Claudia Langenberg; Cordelia Langford; Robert Lawrence; Karin Leander; Jen-Mai Lee; Nanette R Lee; Man Li; Xinzhong Li; Yun Li; Junbin Liang; Samuel Liju; Wei-Yen Lim; Lars Lind; Cecilia M Lindgren; Eero Lindholm; Ching-Ti Liu; Jian Jun Liu; Stéphane Lobbens; Jirong Long; Ruth J F Loos; Wei Lu; Jian'an Luan; Valeriya Lyssenko; Ronald C W Ma; Shiro Maeda; Reedik Mägi; Satu Männisto; David R Matthews; James B Meigs; Olle Melander; Andres Metspalu; Julia Meyer; Ghazala Mirza; Evelin Mihailov; Susanne Moebus; Viswanathan Mohan; Karen L Mohlke; Andrew D Morris; Thomas W Mühleisen; Martina Müller-Nurasyid; Bill Musk; Jiro Nakamura; Eitaro Nakashima; Pau Navarro; Peng-Keat Ng; Alexandra C Nica; Peter M Nilsson; Inger Njølstad; Markus M Nöthen; Keizo Ohnaka; Twee Hee Ong; Katharine R Owen; Colin N A Palmer; James S Pankow; Kyong Soo Park; Melissa Parkin; Sonali Pechlivanis; Nancy L Pedersen; Leena Peltonen; John R B Perry; Annette Peters; Janini M Pinidiyapathirage; Carl G Platou; Simon Potter; Jackie F Price; Lu Qi; Venkatesan Radha; Loukianos Rallidis; Asif Rasheed; Wolfgang Rathman; Rainer Rauramaa; Soumya Raychaudhuri; N William Rayner; Simon D Rees; Emil Rehnberg; Samuli Ripatti; Neil Robertson; Michael Roden; Elizabeth J Rossin; Igor Rudan; Denis Rybin; Timo E Saaristo; Veikko Salomaa; Juha Saltevo; Maria Samuel; Dharambir K Sanghera; Jouko Saramies; James Scott; Laura J Scott; Robert A Scott; Ayellet V Segrè; Joban Sehmi; Bengt Sennblad; Nabi Shah; Sonia Shah; A Samad Shera; Xiao Ou Shu; Alan R Shuldiner; Gunnar Sigurđsson; Eric Sijbrands; Angela Silveira; Xueling Sim; Suthesh Sivapalaratnam; Kerrin S Small; Wing Yee So; Alena Stančáková; Kari Stefansson; Gerald Steinbach; Valgerdur Steinthorsdottir; Kathleen Stirrups; Rona J Strawbridge; Heather M Stringham; Qi Sun; Chen Suo; Ann-Christine Syvänen; Ryoichi Takayanagi; Fumihiko Takeuchi; Wan Ting Tay; Tanya M Teslovich; Barbara Thorand; Gudmar Thorleifsson; Unnur Thorsteinsdottir; Emmi Tikkanen; Joseph Trakalo; Elena Tremoli; Mieke D Trip; Fuu Jen Tsai; Tiinamaija Tuomi; Jaakko Tuomilehto; Andre G Uitterlinden; Adan Valladares-Salgado; Sailaja Vedantam; Fabrizio Veglia; Benjamin F Voight; Congrong Wang; Nicholas J Wareham; Roman Wennauer; Ananda R Wickremasinghe; Tom Wilsgaard; James F Wilson; Steven Wiltshire; Wendy Winckler; Tien Yin Wong; Andrew R Wood; Jer-Yuarn Wu; Ying Wu; Ken Yamamoto; Toshimasa Yamauchi; Mingyu Yang; Loic Yengo; Mitsuhiro Yokota; Robin Young; Delilah Zabaneh; Fan Zhang; Rong Zhang; Wei Zheng; Paul Z Zimmet; David Altshuler; Donald W Bowden; Yoon Shin Cho; Nancy J Cox; Miguel Cruz; Craig L Hanis; Jaspal Kooner; Jong-Young Lee; Mark Seielstad; Yik Ying Teo; Michael Boehnke; Esteban J Parra; Jonh C Chambers; E Shyong Tai; Mark I McCarthy; Andrew P Morris
Journal:  Nat Genet       Date:  2014-02-09       Impact factor: 38.330

View more
  16 in total

Review 1.  Progress in Defining the Genetic Basis of Diabetic Complications.

Authors:  Emma Dahlström; Niina Sandholm
Journal:  Curr Diab Rep       Date:  2017-09       Impact factor: 4.810

2.  Genome-wide identification of m6A-associated SNPs as potential functional variants for bone mineral density.

Authors:  X B Mo; Y H Zhang; S F Lei
Journal:  Osteoporos Int       Date:  2018-07-07       Impact factor: 4.507

3.  Association Analysis of the Cubilin (CUBN) and Megalin (LRP2) Genes with ESRD in African Americans.

Authors:  Jun Ma; Meijian Guan; Donald W Bowden; Maggie C Y Ng; Pamela J Hicks; Janice P Lea; Lijun Ma; Chuan Gao; Nicholette D Palmer; Barry I Freedman
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-19       Impact factor: 8.237

4.  Association Analysis of the Reticulon 1 Gene in End-Stage Kidney Disease.

Authors:  Jason A Bonomo; Nicholette D Palmer; John Cijiang He; Ying Fan; Pamela J Hicks; Janice P Lea; Mark D Okusa; Donald W Bowden; Barry I Freedman
Journal:  Am J Nephrol       Date:  2015-10-24       Impact factor: 3.754

5.  Association of kidney structure-related gene variants with type 2 diabetes-attributed end-stage kidney disease in African Americans.

Authors:  Meijian Guan; Jun Ma; Jacob M Keaton; Latchezar Dimitrov; Poorva Mudgal; Mary Stromberg; Jason A Bonomo; Pamela J Hicks; Barry I Freedman; Donald W Bowden; Maggie C Y Ng
Journal:  Hum Genet       Date:  2016-07-26       Impact factor: 4.132

Review 6.  Genetics, Genomics, and Precision Medicine in End-Stage Kidney Disease.

Authors:  Jeffrey B Kopp; Cheryl A Winkler
Journal:  Semin Nephrol       Date:  2018-07       Impact factor: 5.299

7.  Distinct whole-blood transcriptome profile of children with metabolic healthy overweight/obesity compared to metabolic unhealthy overweight/obesity.

Authors:  Abel Plaza-Florido; Signe Altmäe; Francisco J Esteban; Cristina Cadenas-Sanchez; Concepción M Aguilera; Elisabet Einarsdottir; Shintaro Katayama; Kaarel Krjutškov; Juha Kere; Frank Zaldivar; Shlomit Radom-Aizik; Francisco B Ortega
Journal:  Pediatr Res       Date:  2020-11-23       Impact factor: 3.756

Review 8.  An update on the genetic architecture of hyperuricemia and gout.

Authors:  Tony R Merriman
Journal:  Arthritis Res Ther       Date:  2015-04-10       Impact factor: 5.156

9.  Bioinformatic Evaluation of Transcriptional Regulation of WNT Pathway Genes with reference to Diabetic Nephropathy.

Authors:  Gareth J McKay; David H Kavanagh; John K Crean; Alexander P Maxwell
Journal:  J Diabetes Res       Date:  2015-11-30       Impact factor: 4.011

10.  T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders.

Authors:  Jyoti Rani; Inna Mittal; Atreyi Pramanik; Namita Singh; Namita Dube; Smriti Sharma; Bhanwar Lal Puniya; Muthukurussi Varieth Raghunandanan; Ahmed Mobeen; Srinivasan Ramachandran
Journal:  Sci Rep       Date:  2017-07-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.